Aptus Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Aptus Capital Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$283K	Sell
2025 Q2	$212K	Buy
2025 Q1	–	Sell
2024 Q4	$248K	Buy
2023 Q3	–	Sell
2023 Q2	$234K	Buy